Skip to main content

Dietary Supplement Interaction With Nutrients

  • Chapter
Book cover Handbook of Drug-Nutrient Interactions

Part of the book series: Nutrition and Health ((NH))

Abstract

The retail sales (in food stores, drug stores, mass market outlets) for herbal supplements in 2002 totaled more than $300 million out of pocket in the United States (1). Sales are much greater in other markets (natural food stores, convenience stores, mail order, internet, etc.), although more difficult to estimate. This figure does not take into account expenditures for nutrient and other nonherbal dietary supplements, including minerals and “antioxidant”preparations, which account for many millions of dollars more. It is estimated that 30% of the population has used or is presently using herbal supplements (2). No regulatory agency oversees the manufacture of herbs and dietary supplements, as the passage of the Dietary Supplement Health Education Act in 1994, excluded them from Food and Drug Administration (FDA) surveillance (3). Thus, the true extent and prevalence of interaction of dietary supplements with nutrients is not truly known, and can only be surmised from anecdotal and historical reports, as well as few animal model studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blumenthal M. Market Report. Herbalgram 2002; 55: 60

    Google Scholar 

  2. Robin K. Market Report. Herbalgram 2002; 56: 53

    Google Scholar 

  3. Khatcheressian LA. Regulation of dietary supplements: five years of DSHEA. Food Drug Law J 1999; 54 (4): 623–44

    CAS  Google Scholar 

  4. Brinker F. Herb Contraindications and Drug Interactions. Eclectic Institute, Sandy OR, 1997, pp. 102–103.

    Google Scholar 

  5. Blumenthal M. (ed.). The Complete German Commission E Monographs. American Botanical Council, Integrative Medicine Communications, Boston, MA, 1998

    Google Scholar 

  6. Liu GT. Effects of some compounds isolated from Chinese medicinal herbs on hepatic microsomal cytochrome P-450 and their potential biological consequences. Drug Metab Rev 1991; 23 (3–4): 439–465.

    Article  CAS  Google Scholar 

  7. Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW. Interactions of herbs with cytochrome P450. Drug Metab Rev 2003 Feb; 35 (1): 35–98.

    Article  CAS  Google Scholar 

  8. James JS. St. John’s Wort warning: do not combine with protease inhibitors, NNRTIs. AIDS Treat News 2000;Feb 18(No 337 ): 3–5.

    Google Scholar 

  9. Bauer S, Stormer E, Johne A, et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John’s wort in renal transplant patients. Br J Clin Pharmacol 2003; 55 (2): 203–211.

    Article  CAS  Google Scholar 

  10. Low Dog T, Riley D. Management of Hyperlipidemia. Altern Ther Health Med 2003; 9 (3): 28–40.

    Google Scholar 

  11. Tian R, Koyabu N, Takanaga H, Matsuo H, Ohtani H, Sawada Y. Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res 2002; 19 (6): 802–809.

    Article  CAS  Google Scholar 

  12. Begin F, Vachon C, Jones JD, Wood PJ, Savoie L. Effect of dietary fibers on glycemia and insulinemia and on gastrointestinal function in rats. Can J Physiol Pharmacol 1989; 67 (10): 1265–1271.

    Article  CAS  Google Scholar 

  13. Kinne-Saffran E, Kinne RK. Herbal diuretics revisited: from “wise women”to William Withering. Am J Nephrol 2002; 22 (2–3): 112–118.

    Article  Google Scholar 

  14. Walker BR, Edwards CR. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin North Am 1994; 23 (2): 359–377.

    CAS  Google Scholar 

  15. Armanini D, Lewicka S, Pratesi C, et al. Further studies on the mechanism of the mineralocorticoid action of licorice in humans. J Endocrinol Invest 1996; 19 (9): 624–629.

    CAS  Google Scholar 

  16. Neto MM, Da Costa JA, Garcia-Cairasco N, Netto JC, Nakagawa B, Dantas M. Intoxication by star fruit (Averrhoa carambola) in 32 uraemic patients: treatment and outcome. Nephrol Dial Transplant 2003; 18 (1): 120–125.

    Article  Google Scholar 

  17. Chen CL, Fang HC, Chou KJ, Wang JS, Chung HM. Acute oxalate nephropathy after ingestion of star fruit. Am J Kidney Dis 2001; 37 (2): 418–422.

    Article  CAS  Google Scholar 

  18. Frati Munari AC, Benitez Pinto W, Raul Ariza Andraca C, Casarrubias M. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage. Arch Med Res 1998; 29 (2): 137–141.

    Google Scholar 

  19. Liu F, Kim J, Li Y, Liu X, Li J, Chen X. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3–L1 cells. J Nutr 2001; 131 (9): 2242–2247.

    CAS  Google Scholar 

  20. Wang HX, Ng TB. Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life Sci 1999; 65 (25): 2663–2677.

    Article  CAS  Google Scholar 

  21. Wang BX, Zhou QL, Yang M, Cui ZY, Liu YQ. Ikejima T. Hypoglycemic mechanism of ginseng glycopeptide. Acta Pharmacol Sin 2003; 24 (1): 61–66

    Google Scholar 

  22. Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm 2003; 60 (4): 356–359.

    Google Scholar 

  23. Ye W, Liu X, Zhang Q, Che CT, Zhao S. Antisweet saponins from Gymnema sylvestre. J Nat Prod 2001; 64 (2): 232–235.

    Article  CAS  Google Scholar 

  24. Persaud SJ, Al-Majed H, Raman A, Jones PM. Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. J Endocrinol 1999; 163 (2): 207–212.

    Article  CAS  Google Scholar 

  25. Yeh YY, Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr 2001; 131 (3s): 989S–93S.

    CAS  Google Scholar 

  26. Yeh YY, Yeh SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids. 1994; 29 (3): 189–193.

    Article  CAS  Google Scholar 

  27. Man RY, Lynn EG, Cheung F, Tsang PS, O K. Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2). Mol Cell Biochem 2002; 233 (1–2): 153–158.

    Article  CAS  Google Scholar 

  28. Prasad GV, Wong T, Meliton G, Bhaloo S. Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation 2002; 74 (8): 1200–1201.

    Article  Google Scholar 

  29. McCarthy M. FDA bans red yeast rice product. Lancet 1998; 351: 1637

    Article  Google Scholar 

  30. Urizar NL, Moore DD. Gugulipid: A Natural Cholesterol-Lowering Agent. Annu Rev Nutr 2003; 23: 303–313.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Markell, M. (2004). Dietary Supplement Interaction With Nutrients. In: Boullata, J.I., Armenti, V.T. (eds) Handbook of Drug-Nutrient Interactions. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-781-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-781-9_12

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5359-2

  • Online ISBN: 978-1-59259-781-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics